ACOFENAC

This brand name is authorized in Nigeria.

Active ingredients

The drug ACOFENAC contains one active pharmaceutical ingredient (API):

1
UNII QTG126297Q - DICLOFENAC SODIUM
 

Diclofenac is a non-steroidal anti-inflammatory drug. The mechanism of action of diclofenac in AK may be related to the inhibition of the cycloxygenase pathway leading to reduced prostaglandin E2 (PGE2) synthesis. In addition, immunohistochemistry (IHC) from skin biopsies ac revealed that the clinical effects of diclofenac in AK are primarily due to anti-inflammatory, anti-angiogenic and possibly anti-proliferative effects and apoptosis-inducing mechanisms.

 
Read more about Diclofenac

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
B4-4208 Tablet ACOFENAC TAB 50 mg 10 X 10 65 RNW-PP-193355 ACOFENAC DICLOFENAC SODIUM BP 50MG Name of the Ingredient Mg/Tablet Diclofenac Sodium 50 mg Microcrystalline Cellulose 5.00 mg Purified Talc 7.00 mg Sodium Starch Glycolate 4.00 mg Colloidal Silicon Dioxide 2.00mg Ennar Dummy Granules 42.00 mg Magnesium Stearate 5.00 mg Isopropyl Alcohol - Methylene Di Chloride - INSTACOAT EN SOLE 8.0 mg B4-4208 Drugs Imported Products 1010 Prescription Only Medicine (POM) 12/7/2022 SOLID ACCORD LTD, FEMI KILLA STREET, AGO PALACE WAY, OKOTA - LAGOS LAGOS LAGOS 8168880540 regulatory@solidaccord.com CIRON DRUG & PHARMA PVT LIMITED, PLOT NO 35-37, 43-45 CFC B DEWAN UDYON NAGAR, PALGAR DIST THANE 40404 MAHARASTHRA STATE INDIA, India 06/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
M01AB05 Diclofenac M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AB Acetic acid derivatives and related substances
Discover more medicines within M01AB05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database B4-4208

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.